IPO Profile

MetaBasis Therapeutics Inc.
9390 Towne Centre Drive, Building 300, San Diego, CA 92121
Tel: 858-587-2770
Web: www.mbasis.com
Ticker: MBRX
Stock Exchange: Nasdaq
Shares Issued: 5,000,000.00
Price Offered: $7.00
Amount Raised: $35,000,000.00

Underwriters:
SG Cowen
Deutsche Bank Securities
Thomas Weisel Partners LLC
Legg Mason Wood Walker


Company Description:
We are a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs principally to treat liver diseases and metabolic diseases linked to pathways in the liver. Since we became an independent company in 1999, we have established a broad and growing product pipeline targeting large markets with significant unmet medical needs. We currently have three internally discovered product candidates in clinical trials indicated for the treatment of type 2 diabetes, hepatitis B and primary liver cancer.